Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Public ClinicalTrials.gov record NCT07505004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Study identification
- NCT ID
- NCT07505004
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Praxis Precision Medicines
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- 20 mg/day vormatrogine for 12 weeks Drug
- 30 mg/day vormatrogine for 12 weeks Drug
- 40 mg/day vormatrogine for 12 weeks Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2026
- Primary completion
- Dec 31, 2026
- Completion
- Apr 30, 2027
- Last update posted
- Mar 31, 2026
2026 – 2027
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Praxis Research Site | Miami | Florida | 33133 | Recruiting |
| Praxis Research Site | Miami Lakes | Florida | 33016 | Recruiting |
| Praxis Research Site | Naples | Florida | 34116 | Not yet recruiting |
| Praxis Research Site | Marlboro | New Jersey | 07746 | Recruiting |
| Praxis Research Site | Niagara Falls | New York | 14304 | Recruiting |
| Praxis Research Site | Raleigh | North Carolina | 27607 | Recruiting |
| Praxis Research Site | Houston | Texas | 77058 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07505004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07505004 live on ClinicalTrials.gov.